Related Experiment Video
Updated: May 5, 2026
06:52
Detection of Inflammasome Activation and Pyroptotic Cell Death in Murine Bone Marrow-derived Macrophages
Published on: May 21, 2018
10.2K
Inflammasomes and metabolic disease
Jorge Henao-Mejia1, Eran Elinav, Christoph A Thaiss
1Department of Immunobiology, Yale University School of Medicine, New Haven, Connecticut 06520;
Annual Review of Physiology
|November 27, 2013
Summary
Inflammasomes are key sensors of metabolic changes, linking obesity and immune responses. Understanding this connection is crucial for addressing prevalent metabolic diseases.
Area of Science:
- Immunology
- Metabolic pathways
- Physiology
Background:
- Innate immunity and metabolism are conserved and integrated for survival.
- Metabolic diseases, particularly obesity, are rising globally.
- Obesity highlights the role of innate immunity in metabolic dysfunction.
Purpose of the Study:
- To review evidence on inflammasomes in metabolic diseases.
- To highlight inflammasomes as sensors of metabolic perturbations.
Main Methods:
- Literature review of recent evidence.
Main Results:
- Inflammasomes critically sense metabolic changes in various tissues.
- Inflammasomes play a role in the progression of common metabolic diseases.
Conclusions:
- Inflammasomes are central to the pathophysiology of obesity-related metabolic diseases.
- Targeting inflammasomes may offer therapeutic strategies for metabolic disorders.
Related Concept Videos
01:12Chronic Inflammation: Introduction
50
Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...
50
01:25Inflammatory Bowel Disease III: Crohn's Disease
69
Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
69
01:24Overview of Lipid Metabolism
7.0K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
7.0K
01:21Acute Pancreatitis II: Pathophysiology
49
The pathophysiology of acute pancreatitis centers on injury to pancreatic acinar cells, which initiates a cascade of harmful intracellular events.This injury leads to premature activation of trypsinogen to trypsin in the pancreas. Trypsin then activates other digestive enzymes, such as chymotrypsin, elastase, and phospholipase A2, which begin breaking down pancreatic tissue. The resulting autodigestion causes local inflammation, tissue swelling, hemorrhage, and fat necrosis.Injured acinar cells...
49
01:38Inflammation
46.8K
Overview
46.8K
01:26Type II Diabetes I: Introduction
57
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
57